{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:17:18Z","timestamp":1782235038988,"version":"3.54.5"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cytogfr.2024.08.002","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:03:05Z","timestamp":1723680185000},"page":"43-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The intersection of microbiome and autoimmunity in long COVID-19: Current insights and future directions"],"prefix":"10.1016","volume":"82","author":[{"given":"Altijana","family":"Hromi\u0107-Jahjefendi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejla","family":"Mahmutovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abas","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Be\u0107irevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Rubio-Casillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elrashdy M.","family":"Redwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2024.08.002_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110495","article-title":"COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity","volume":"101","author":"Lundstrom","year":"2023","journal-title":"Cell Signal"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib3","article-title":"Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?","volume":"11","author":"Hromi\u0107-Jahjefendi\u0107","year":"2023","journal-title":"Vaccin. (Basel)"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/v14050910","article-title":"Associations and disease-disease interactions of COVID-19 with congenital and genetic disorders: a comprehensive review","volume":"14","author":"Hromi\u0107-Jahjefendi\u0107","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jcb.30514","article-title":"Intrinsic factors behind long COVID: III. Persistence of SARS-CoV-2 and its components","volume":"125","author":"El-Baky","year":"2024","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib6","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jcb.30486","article-title":"Intrinsic factors behind long-COVID: II. SARS-CoV-2, extracellular vesicles, and neurological disorders","volume":"124","author":"El-Maradny","year":"2023","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jcb.30415","article-title":"Intrinsic factors behind long-COVID: I. Prevalence of the extracellular vesicles","volume":"124","author":"El-Maradny","year":"2023","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091405","article-title":"A Comprehensive Insight into the Role of Exosomes in Viral Infection: Dual Faces Bearing Different Functions","volume":"13","author":"Saad","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib9","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1080\/07391102.2020.1790426","article-title":"On the potential role of exosomes in the COVID-19 reinfection\/reactivation opportunity","volume":"39","author":"Elrashdy","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","article-title":"Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study","volume":"400","author":"Ballering","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis","volume":"101","author":"Ceban","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib12","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib14","doi-asserted-by":"crossref","first-page":"m3026","DOI":"10.1136\/bmj.m3026","article-title":"Management of post-acute covid-19 in primary care","volume":"370","author":"Greenhalgh","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib15","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jinf.2020.08.029","article-title":"Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19","volume":"81","author":"Garrigues","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.it.2022.02.008","article-title":"Early clues regarding the pathogenesis of long-COVID","volume":"43","author":"Peluso","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1017\/neu.2022.21","article-title":"Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision nomothetic approach","volume":"35","author":"Al-Hadrawi","year":"2023","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41584-019-0352-1","article-title":"NETs spread ever wider in rheumatic diseases","volume":"16","author":"Wigerblad","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nm.4044","article-title":"Oxidation and mitochondrial origin of NET DNA in the pathogenesis of lupus","volume":"22","author":"Muller","year":"2016","journal-title":"Nat. Med"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092942","article-title":"Neutrophil Extracellular Traps and By-Products Play a Key Role in COVID-19: Pathogenesis, Risk Factors, and Therapy","volume":"9","author":"Thierry","year":"2020","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib21","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02245-2021","article-title":"Long COVID: to investigate immunological mechanisms and sex\/gender related aspects as fundamental steps for tailored therapy","volume":"59","author":"Ortona","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103143","article-title":"Seronegative autoimmune diseases: A challenging diagnosis","volume":"21","author":"Lenti","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102695","article-title":"SARS-CoV-2, the autoimmune virus","volume":"19","author":"Halpert","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib26","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/cts.12805","article-title":"Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19","volume":"13","author":"Zhou","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib28","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/infdis\/jiac017","article-title":"Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome","volume":"225","author":"Acosta-Ampudia","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12967-022-03328-4","article-title":"Autoimmunity is a hallmark of post-COVID syndrome","volume":"20","author":"Rojas","year":"2022","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/infdis\/jiac372","article-title":"Low Prevalence of Interferon \u03b1 Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID","volume":"227","author":"Peluso","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib31","article-title":"Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms","volume":"61","author":"Son","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100100","article-title":"Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms","volume":"4","author":"Wallukat","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib33","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.158.6.2756","article-title":"Human autoreactive CD4+ T cell clones use perforin- or Fas\/Fas ligand-mediated pathways for target cell lysis","volume":"158","author":"Vergelli","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib34","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.4049\/jimmunol.158.11.5283","article-title":"Perforin, Fas\/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL","volume":"158","author":"Ando","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib35","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1074\/jbc.M110.169417","article-title":"Human perforin employs different avenues to damage membranes","volume":"286","author":"Praper","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib36","doi-asserted-by":"crossref","first-page":"9172","DOI":"10.1074\/jbc.M113.544890","article-title":"The perforin pore facilitates the delivery of cationic cargos","volume":"289","author":"Stewart","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature09518","article-title":"The structural basis for membrane binding and pore formation by lymphocyte perforin","volume":"468","author":"Law","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib38","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jmii.2022.09.001","article-title":"Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery","volume":"55","author":"Ruenjaiman","year":"2022","journal-title":"J. Microbiol Immunol. Infect."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.922422","article-title":"Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome","volume":"12","author":"Queiroz","year":"2022","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257016","article-title":"Development of ACE2 autoantibodies after SARS-CoV-2 infection","volume":"16","author":"Arthur","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031716","article-title":"SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19","volume":"23","author":"Gusev","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.595150","article-title":"Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients","volume":"12","author":"Hammoudeh","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study","volume":"56","author":"Chang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib45","article-title":"Autoantibody production is enhanced after mild SARS-CoV-2 infection despite vaccination in individuals with and without long COVID","author":"Visvabharathy","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163669","article-title":"Chronic viral coinfections differentially affect the likelihood of developing long COVID","volume":"133","author":"Peluso","year":"2023","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib47","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19","volume":"375","author":"Merad","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib48","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1073\/pnas.0903602106","article-title":"Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system","volume":"106","author":"Stegbauer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.regpep.2006.01.007","article-title":"Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study","volume":"134","author":"Rasini","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib50","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212553","article-title":"SARS-CoV-2 infection relaxes peripheral B cell tolerance","volume":"219","author":"Castleman","year":"2022","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12964-023-01044-0","article-title":"SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis","volume":"21","author":"Lee","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/db15-0399","article-title":"ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity","volume":"65","author":"Patel","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib53","doi-asserted-by":"crossref","first-page":"n136","DOI":"10.1136\/bmj.n136","article-title":"Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline","volume":"372","author":"Shah","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvac115","volume":"119","author":"Gy\u00f6ngy\u00f6si","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28209","article-title":"Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients","volume":"95","author":"Pisareva","year":"2023","journal-title":"J. Med Virol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152025","article-title":"DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study","volume":"55","author":"Di Iorio","year":"2022","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib57","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/cid\/ciab611","article-title":"Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study","volume":"74","author":"See\u00dfle","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","article-title":"Human genetic and immunological determinants of critical COVID-19 pneumonia","volume":"603","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib60","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/S2666-5247(22)00036-2","article-title":"SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study","volume":"3","author":"Guo","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1029006","article-title":"Low perforin expression in CD8+ T lymphocytes during the acute phase of severe SARS-CoV-2 infection predicts long COVID","volume":"13","author":"Kundura","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.848886","article-title":"Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers","volume":"13","author":"Gal\u00e1n","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib63","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1093\/cid\/ciac655","article-title":"Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study","volume":"76","author":"Fjelltveit","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886431","article-title":"Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection","volume":"13","author":"Wiech","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400121","article-title":"Distinct plasma immune signatures in ME\/CFS are present early in the course of illness","volume":"1","author":"Hornig","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib66","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s10067-023-06670-0","article-title":"Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study","volume":"42","author":"Tesch","year":"2023","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib67","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-021-00709-9","article-title":"Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison","volume":"17","author":"Sharma","year":"2021","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib68","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1038\/s41467-023-40460-1","article-title":"Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity","volume":"14","author":"Altmann","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102154","article-title":"Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study","volume":"63","author":"Peng","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib70","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/ijmm.2020.4659","article-title":"Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)","volume":"46","author":"Cavalli","year":"2020","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib71","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/annrheumdis-2021-220206","article-title":"Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients","volume":"80","author":"Trahtemberg","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.732197","article-title":"SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS","volume":"13","author":"Juanes-Velasco","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib73","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/all.15302","article-title":"Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures","volume":"77","author":"Taeschler","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28538","article-title":"Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity","volume":"95","author":"Baiocchi","year":"2023","journal-title":"J. Med Virol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110873","article-title":"Serum autoantibodyome reveals that healthy individuals share common autoantibodies","volume":"39","author":"Shome","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib76","first-page":"151","article-title":"Natural autoantibodies to apoptotic cell membranes regulate fundamental innate immune functions and suppress inflammation","volume":"8","author":"Silverman","year":"2009","journal-title":"Discov. Med"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib77","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib78","first-page":"2","volume":"18","author":"Baquero","year":"2012","journal-title":"Micro a Hum. Organ"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib79","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","article-title":"Gut flora in health and disease","volume":"361","author":"Guarner","year":"2003","journal-title":"lancet"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib80","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.aad9378","article-title":"How colonization by microbiota in early life shapes the immune system","volume":"352","author":"Gensollen","year":"2016","journal-title":"Science"},{"issue":"1125-1136","key":"10.1016\/j.cytogfr.2024.08.002_bib81","article-title":"Ter Horst, R.; Jansen, T.; Jacobs, L.; Bonder, M.J. Linking the human gut microbiome to inflammatory cytokine production capacity","volume":"167","author":"Schirmer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib82","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib83","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124370","article-title":"Microbiota-dependent signals are required to sustain TLR-mediated immune responses","volume":"4","author":"Weaver","year":"2019","journal-title":"JCI Insight"},{"issue":"944-955","key":"10.1016\/j.cytogfr.2024.08.002_bib84","article-title":"Alterations in gut microbiota of patients with COVID-19 during time of hospitalization","volume":"159","author":"Zuo","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib85","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","article-title":"Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19","volume":"70","author":"Yeoh","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib86","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01969-20","article-title":"Metagenomic next-generation sequencing of nasopharyngeal specimens collected from confirmed and suspect COVID-19 patients","volume":"11","author":"Mostafa","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib87","article-title":"Correction to: Ventilator-associated pneumonia in critically ill patients with COVID-19","volume":"25","author":"Maes","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib88","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib89","article-title":"Lower gut abundance of Eubacterium rectale is linked to COVID-19 mortality","volume":"13","author":"Liu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib90","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3390\/ijerph18042174","article-title":"Investigation of nasal\/oropharyngeal microbial community of COVID-19 patients by 16S rDNA sequencing","volume":"18","author":"Rueca","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-023-04356-2","article-title":"Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19","volume":"27","author":"Tr\u00f8seid","year":"2023","journal-title":"Crit. Care"},{"issue":"872-882","key":"10.1016\/j.cytogfr.2024.08.002_bib92","article-title":"Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations","volume":"136","author":"Camargo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib93","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature11228","article-title":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation","volume":"487","author":"Hashimoto","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib94","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.micinf.2013.08.003","article-title":"ACE2\u2013From the renin\u2013angiotensin system to gut microbiota and malnutrition","volume":"15","author":"Perlot","year":"2013","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101123","article-title":"ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities\u2013role of gut microbiota dysbiosis","volume":"62","author":"Viana","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib96","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib97","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e120","article-title":"Gut microbiota dysbiosis correlates with long COVID-19 at one-year after discharge","volume":"38","author":"Zhang","year":"2023","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib98","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/pathophysiology29020020","article-title":"The role of exposomes in the pathophysiology of autoimmune diseases II: Pathogens","volume":"29","author":"Vojdani","year":"2022","journal-title":"Pathophysiology"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib99","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cotox.2017.10.012","article-title":"Environmental agents, oxidative stress and autoimmunity","volume":"7","author":"Khan","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/BOR.0000000000000574","article-title":"The microbiome in systemic autoimmune disease: mechanistic insights from recent studies","volume":"31","author":"Dehner","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib101","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cei.13158","article-title":"The microbiome in autoimmune diseases","volume":"195","author":"De Luca","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib102","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/cmi.2018.7","article-title":"The microbiome and autoimmunity: a paradigm from the gut\u2013liver axis","volume":"15","author":"Li","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198757","article-title":"Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease","volume":"13","author":"Abe","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2220","article-title":"Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice","volume":"12","author":"Choi","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12765","article-title":"Intestinal dysbiosis and probiotic applications in autoimmune diseases","volume":"152","author":"de Oliveira","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib106","first-page":"574","article-title":"Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study","volume":"20","author":"Harbison","year":"2019","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib107","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4835189","article-title":"Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis","volume":"2017","author":"Horta-Baas","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.906258","article-title":"Microbial dysbiosis in the gut drives systemic autoimmune diseases","volume":"13","author":"Mousa","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib109","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/art.39783","article-title":"Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine","volume":"68","author":"Maeda","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12602-021-09802-7","article-title":"Interplay of microbiota and citrullination in the immunopathogenesis of rheumatoid arthritis","volume":"14","author":"Alghamdi","year":"2022","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib111","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: a cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-017-0300-8","article-title":"Control of lupus nephritis by changes of gut microbiota","volume":"5","author":"Mu","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib113","article-title":"Intestinal dysbiosis associated with Systemic Lupus Erythematosus","author":"Hevia","year":"2014","journal-title":"Highlights Microb. Targets Interv. Strateg."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib114","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","article-title":"Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal","volume":"78","author":"Azzouz","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib115","article-title":"The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs","volume":"9","author":"Shi","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib116","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/art.40935","article-title":"A link between plasma microbial translocation, microbiome, and autoantibody development in first-degree relatives of systemic lupus erythematosus patients","volume":"71","author":"Ogunrinde","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006315","article-title":"Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9","volume":"13","author":"Tursi","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib118","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.immuni.2015.06.002","article-title":"Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity","volume":"42","author":"Gallo","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib119","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","article-title":"The microbiome and inflammatory bowel disease","volume":"145","author":"Glassner","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/brainsci10040234","article-title":"Microbiome in multiple sclerosis: where are we, what we know and do not know","volume":"10","author":"Boziki","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib121","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1128\/AEM.02676-14","article-title":"Dynamics of gut microbiota in autoimmune lupus","volume":"80","author":"Zhang","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib122","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/nu10081016","article-title":"Retinoic acid, leaky gut, and autoimmune diseases","volume":"10","author":"Abdelhamid","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib123","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/medicines8090047","article-title":"A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of post-COVID fatigue","volume":"8","author":"Rathi","year":"2021","journal-title":"Medicines"},{"issue":"2002","key":"10.1016\/j.cytogfr.2024.08.002_bib124","first-page":"21249256","article-title":"Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME\/CFS) following the first pandemic wave in Germany\u2013a first analysis of a prospective observational study","volume":"2021","author":"Kedor","year":"2006","journal-title":"MedRxiv 2021"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib125","article-title":"COVID-19 and post-infectious myalgic encephalomyelitis\/chronic fatigue syndrome: a narrative review","volume":"8","author":"Poenaru","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib126","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/brainsci10121012","article-title":"Post-COVID-19 fatigue: potential contributing factors","volume":"10","author":"Rudroff","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110055","article-title":"Into the looking glass: Post-viral syndrome post COVID-19","volume":"144","author":"Perrin","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105465","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): Where will the drugs come from?","volume":"165","author":"Toogood","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8063647","article-title":"Immunomodulatory effects of probiotics on cytokine profiles","volume":"2018","author":"Azad","year":"2018","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1611-4","article-title":"Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review","volume":"16","author":"Morshedi","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/nu9050521","article-title":"Antioxidant properties of probiotic bacteria","volume":"9","author":"Wang","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib132","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/s41598-019-39602-7","article-title":"Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055","volume":"9","author":"Eguchi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib133","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1684198","article-title":"Modification of immunological parameters, oxidative stress markers, mood symptoms, and well-being status in CFS patients after probiotic intake: observations from a pilot study","volume":"2019","author":"Venturini","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib134","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12275-018-8032-4","article-title":"Mind-altering with the gut: Modulation of the gut-brain axis with probiotics","volume":"56","author":"Kim","year":"2018","journal-title":"J. Microbiol."},{"key":"10.1016\/j.cytogfr.2024.08.002_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00164","article-title":"Effects of probiotics on cognitive reactivity, mood, and sleep quality","volume":"10","author":"Marotta","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.cytogfr.2024.08.002_bib136","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jad.2017.11.063","article-title":"A meta-analysis of the use of probiotics to alleviate depressive symptoms","volume":"228","author":"Ng","year":"2018","journal-title":"J. Affect. Disord."}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610124000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610124000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T17:20:30Z","timestamp":1741800030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610124000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":136,"alternative-id":["S1359610124000625"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2024.08.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The intersection of microbiome and autoimmunity in long COVID-19: Current insights and future directions","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2024.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}